Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$422M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$411M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$351M |
| 4 |
Pfizer
PFE
|
+$331M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.28B |
| 2 |
Meta Platforms (Facebook)
META
|
+$989M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$953M |
| 4 |
Amazon
AMZN
|
+$816M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$782M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.23% |
| 2 | Technology | 2.06% |
| 3 | Consumer Discretionary | 1.41% |
| 4 | Healthcare | 0.83% |
| 5 | Financials | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
CALL
SSR Mining
SSRM
$7.95B
| $10.2M | ﹤0.01% |
947,700
-149,400
| -14% | -$1.81M |
|
2602
CALL
Lumentum
LITE
$85.8B
| $10.2M | ﹤0.01% |
194,400
-192,800
| -50% | -$8.4M |
|
2603
CALL
Harley-Davidson
HOG
$2.9B
| $10.2M | ﹤0.01% |
276,600
+6,600
| +2% | +$203K |
|
2604
Stanley Black & Decker
SWK
$15B
| $10.2M | ﹤0.01% |
103,787
+32,966
| +47% | +$2.9M |
|
2605
Leidos
LDOS
$17.6B
| $10.2M | ﹤0.01% |
94,000
+12,882
| +16% | +$1.31M |
|
2606
PUT
Intellia Therapeutics
NTLA
$1.84B
| $10.2M | ﹤0.01% |
332,900
+234,600
| +239% | +$6.74M |
|
2607
PUT
Viking Therapeutics
VKTX
$3.95B
| $10.1M | ﹤0.01% |
544,900
+133,500
| +32% | +$1.75M |
|
2608
CALL
Warrior Met Coal
HCC
$5.72B
| $10.1M | ﹤0.01% |
166,200
+71,300
| +75% | +$3.76M |
|
2609
Invesco Short Term Treasury ETF
TBLL
$2.58B
| $10.1M | ﹤0.01% |
+95,823
| New | +$10.1M |
|
2610
CALL
Biomea Fusion
BMEA
$122M
| $10.1M | ﹤0.01% |
696,600
+676,800
| +3,418% | +$8.22M |
|
2611
CALL
Altimmune
ALT
$630M
| $10.1M | ﹤0.01% |
898,900
+624,200
| +227% | +$2.61M |
|
2612
Hamilton Lane
HLNE
$4.63B
| $10.1M | ﹤0.01% |
89,069
+15,114
| +20% | +$1.43M |
|
2613
Global X Lithium & Battery Tech ETF
LIT
$1.65B
| $10.1M | ﹤0.01% |
198,319
+160,056
| +418% | +$7.93M |
|
2614
CBRE Group
CBRE
$42.6B
| $10.1M | ﹤0.01% |
108,461
-13,952
| -11% | -$1.08M |
|
2615
CALL
Perrigo
PRGO
$1.99B
| $10.1M | ﹤0.01% |
313,200
-36,800
| -11% | -$1.1M |
|
2616
Calix
CALX
$2.37B
| $10.1M | ﹤0.01% |
230,680
+216,484
| +1,525% | +$8.66M |
|
2617
CALL
M/I Homes
MHO
$3.82B
| $10.1M | ﹤0.01% |
73,000
-38,400
| -34% | -$3.84M |
|
2618
Tenable Holdings
TENB
$4.14B
| $10.1M | ﹤0.01% |
218,220
+168,323
| +337% | +$7.08M |
|
2619
PUT
Stellantis
STLA
$19.9B
| $10.1M | ﹤0.01% |
431,000
-195,500
| -31% | -$4.04M |
|
2620
CALL
United Therapeutics
UTHR
$22.6B
| $10M | ﹤0.01% |
45,700
-3,100
| -6% | -$715K |
|
2621
CALL
Herbalife
HLF
$1.29B
| $10M | ﹤0.01% |
657,800
+253,400
| +63% | +$3.5M |
|
2622
PUT
Trump Media & Technology Group
DJT
$2.72B
| $10M | ﹤0.01% |
572,200
-208,800
| -27% | -$3.41M |
|
2623
PUT
Jacobs Solutions
J
$17.6B
| $10M | ﹤0.01% |
93,212
+36,390
| +64% | +$3.96M |
|
2624
Cognex
CGNX
$10.6B
| $10M | ﹤0.01% |
239,638
+225,160
| +1,555% | +$8.65M |
|
2625
GlobalFoundries
GFS
$25.4B
| $10M | ﹤0.01% |
165,035
+120,703
| +272% | +$6.69M |
|
Similar funds
Jeff Yass's Q4 2023 Portfolio in Review
As of Q4 2023, Jeff Yass held 13,823 positions worth $525B, up 9.3% from $481B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q4 2023 filing shows 1,903 new, 5,066 increased, 5,122 reduced and 1,577 closed positions. Its largest new stake was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.28B.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2023 buy was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M.
- Jeff Yass added most to Alibaba in Q4 2023, an estimated $422M increase.
- Jeff Yass's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.28B.
- Jeff Yass fully exited VMware, Inc in Q4 2023, selling an estimated $313M.
- Jeff Yass's ten largest holdings make up 24% of its $525B portfolio in Q4 2023.
- Jeff Yass opened 1,903 new positions and closed 1,577 in Q4 2023.
- Jeff Yass's portfolio value rose 9.3% quarter-over-quarter to $525B.
Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.